Nuvation will launch two new studies of safusidenib in glioma, a global pivotal trial and a Phase II trial in the US.
Proposal Submitted to the Republic of Iraq- SIINA 9.4 EGB-AI - Session (4) Scientific Article (F)- SAMANSIC Coalition ...
GE HealthCare today announced the introduction of MIM Anywaretm, a remote access platform that provides secure, healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results